MIN/Sp/AU/CAMH3/6 Malaria Page 21 Table 3: Summary of IRS country profiles, 2006-2007 malaria seasons Country Angola Botswana Burundi Cape Verde Eritrea Ethiopia Equatorial Guinea Ghana Kenya Madagascar Mauritius[2] Mozambique Namibia Sao Tomé & Principe South Africa Swaziland Tanzania/Mainland Tanzania/Zanzibar Uganda Zambia Zimbabwe Total population (million) 15.4 1.7 7 0.23 3.6 73 0.5 21.5 32 18 1.2 19 2 0.15 Population at risk (million) 15.4 0.7 6.6 0.23 2.4 50 0.5 21.5 22 18 -19 0.7 0.15 Population covered (million) 0.65 0.43 0.098 -0.2 5.98 -0.23 0.55 1.25 -5.7 0.4 0.14 Average operational coverage (%)[1] 95 73 96.5 -93 87.2 60 -16 98 -91 86 87 45 1 33 1.2 26 11 12 4.5 0.5 32 1.2 24.7 11 5.5 4 0.4 (80% of at risk) -1.02 0.49 0.77(40% of at risk) 2.2 (68% of at risk) 83 93 -96 96 84 82 Source: Adopted from WHO/AFRO (2007) Overview of the Implementation of Indoor Residual Spraying of Insecticides for Malaria Control in the WHO African Region 2006 – 2007 2.5 Access to affordable medicines and technologies Globally, ACTs are the recommended 1st line treatment for uncomplicated malaria. As a result, all but 2 countries in AFRO have adopted this policy. As discussed earlier, there is always a lag between adoption of the policy and implementation due to cost of medication, weak procurement and supply systems, etc. Since 2003, there has been an increase in the production and procurement of ACTs. In addition, funding initiatives such as the Global Fund, PMI, World Bank Booster Programme and UNITAID have provided funding to countries to implement the ACT policies. As a result, there is a marked increase in the procurement of ACTs globally. Whereas only 3,000,000 ACT doses were procured in 2003, in 2006 over 100,000,000 doses were procured globally. The Affordable Medicines facility for Malaria (AMFm) was established to bring down the cost of ACTs. The facility will also ensure that the Artemesinin monotherapies Status Report on Malaria in Africa 2008